“…Antibodies are glycoproteins bearing two biantennary glycan chains, , typically composed of a core pentasaccharide and varying numbers of galactose (Gal), N -acetylneuraminic acid (NeuNAc), fucose (Fuc), mannose (Man), and N -acetylglucosamine (GlcNAc) . During the course of glycosylation, the glycans are attached to the conserved asparagine residue at position 297 (Asn-297) in the C H 2 domain of the fragment crystallizable region, and they are the main effectors of the antibody-dependent cellular cytotoxicity (ADCC) and the complement-dependent cytotoxicity (CDC) of antibody pharmaceuticals. , Taking Gal, Fuc, and Man as examples, it can be seen that the glycans of antibodies carry tens of the vicinal diol sites. , As the diol sites can covalently cross-link with the boronic acid group, , the attached glycans can be harnessed for the amplified detection of antibody pharmaceuticals.…”